医学影像等领域的医疗器械
Search documents
深圳惠泰医疗器械股份有限公司 关于股东权益变动的提示性公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-09-05 04:49
Core Viewpoint - Shenzhen Huatai Medical Instruments Co., Ltd. (the "Company") announced that its controlling shareholder, Shenzhen Mindray Technology Holdings Co., Ltd. ("Mindray"), increased its stake in the Company through a block trade, raising its ownership from 24.54% to 25.00% [2][4]. Group 1: Shareholding Changes - Mindray acquired an additional 655,536 shares, representing a 0.46% increase in its stake [2][3]. - Prior to this transaction, Mindray and its concerted party, Zhuhai Tongsheng Investment Partnership (Limited Partnership), held a total of 34,597,913 shares [2][3]. - Following the transaction, the total shares held by Mindray and Zhuhai Tongsheng increased to 35,253,449 shares [2][3]. Group 2: Transaction Details - The acquisition was executed through a block trade, with the total transaction amounting to approximately 162.70 million yuan, at a price of 248.20 yuan per share [27][28]. - The funds for this transaction were sourced entirely from Mindray's own or self-raised funds, with no involvement from the Company or its affiliates [3][28]. Group 3: Regulatory Compliance - The shareholding increase does not trigger a mandatory tender offer and will not result in a change of control of the Company [4][5]. - The transaction complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Management Measures for the Acquisition of Listed Companies [5][40]. Group 4: Future Plans - Mindray and its concerted party currently have no plans to further increase their stake in the Company within the next 12 months [24][30]. - There are no plans to change the Company's main business or make significant adjustments to its operations in the near future [30][31].
惠泰医疗: 中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司详式权益变动报告书之财务顾问核查意见
Zheng Quan Zhi Xing· 2025-09-04 16:21
Core Viewpoint - The financial advisory opinion from CITIC Securities confirms the accuracy and completeness of the detailed equity change report for Shenzhen Huatai Medical Devices Co., Ltd, ensuring compliance with relevant laws and regulations [1][2]. Section Summaries Section 1: Definitions - The document defines key terms related to the equity change report, including the parties involved and the nature of the equity change, specifically the acquisition of 655,536 shares, representing 0.46% of the total share capital of Huatai Medical [1]. Section 2: Verification of the Detailed Equity Change Report - The report is divided into thirteen parts, covering various aspects such as the purpose of the equity change, funding sources, and the impact on the listed company. The financial advisor conducted a thorough due diligence process and found the report's content to be true, accurate, and complete [1][2]. Section 3: Verification of the Information Disclosure Obligor - The basic information of Shenzhen Mindray Technology Holdings Co., Ltd is provided, including its registration details, legal representative, and business scope. The advisor confirms that the entity is legally established and has the qualifications for the equity change [2][3]. Section 4: Financial Status of the Information Disclosure Obligor - Financial data for Shenzhen Mindray Technology Holdings over the last three years is presented, showing total assets of approximately 1.6 billion yuan in 2024, with a net profit of about 85 million yuan. The company has maintained a low debt ratio of 15.36% [7][8]. Section 5: Legal and Compliance History - The information disclosure obligor has not faced any administrative or criminal penalties in the last five years, nor has it been involved in significant civil litigation or arbitration related to economic disputes [7][8]. Section 6: Management Verification - The document verifies the qualifications of the executive director and supervisor of the information disclosure obligor, confirming no legal issues in the past five years [7][8]. Section 7: Shareholding in Other Companies - The advisor confirms that the information disclosure obligor and its controlling shareholders do not hold more than 5% of shares in any other listed companies, aside from their interests in Mindray Medical and Huatai Medical [7][8]. Section 8: Verification of Consistent Action Parties - The document provides details about Zhuhai Tongsheng Investment Partnership, including its registration, capital contribution, and business scope. The advisor confirms its legal establishment and compliance with regulations [8].